133 related articles for article (PubMed ID: 11313943)
41. Differential effect of the focal adhesion kinase Y397F mutant on v-Src-stimulated cell invasion and tumor growth.
Chang LC; Huang CH; Cheng CH; Chen BH; Chen HC
J Biomed Sci; 2005; 12(4):571-85. PubMed ID: 16132110
[TBL] [Abstract][Full Text] [Related]
42. SSeCKS/Gravin/AKAP12 attenuates expression of proliferative and angiogenic genes during suppression of v-Src-induced oncogenesis.
Liu Y; Gao L; Gelman IH
BMC Cancer; 2006 Apr; 6():105. PubMed ID: 16638134
[TBL] [Abstract][Full Text] [Related]
43. c-Jun causes focus formation and anchorage-independent growth in culture but is non-tumorigenic.
Wong WY; Håvarstein LS; Morgan IM; Vogt PK
Oncogene; 1992 Oct; 7(10):2077-80. PubMed ID: 1408150
[TBL] [Abstract][Full Text] [Related]
44. Ligand-specific control of src-suppressed C kinase substrate gene expression.
Coats SR; Pabón-Peña LM; Covington JW; Vaughan DE
Biochem Biophys Res Commun; 2002 Oct; 297(5):1112-20. PubMed ID: 12372401
[TBL] [Abstract][Full Text] [Related]
45. Identification and characterization of genes upregulated in cells transformed by v-Jun.
Fu SL; Waha A; Vogt PK
Oncogene; 2000 Jul; 19(31):3537-45. PubMed ID: 10918612
[TBL] [Abstract][Full Text] [Related]
46. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
[TBL] [Abstract][Full Text] [Related]
47. p60(v-src) and serum control cell shape and apoptosis via distinct pathways in quail neuroretina cells.
Aouacheria A; Ory S; Schmitt JR; Rigal D; Jurdic P; Gillet G
Oncogene; 2002 Feb; 21(8):1171-86. PubMed ID: 11850837
[TBL] [Abstract][Full Text] [Related]
48. Stable expression of intracellular Notch suppresses v-Src-induced transformation in avian neural cells.
Mateos S; Amarir S; Laugier D; Marx M; Calothy G
Oncogene; 2007 May; 26(23):3338-51. PubMed ID: 17146440
[TBL] [Abstract][Full Text] [Related]
49. Down-regulation of overexpressed sp1 protein in human fibrosarcoma cell lines inhibits tumor formation.
Lou Z; O'Reilly S; Liang H; Maher VM; Sleight SD; McCormick JJ
Cancer Res; 2005 Feb; 65(3):1007-17. PubMed ID: 15705902
[TBL] [Abstract][Full Text] [Related]
50. Stepwise neoplastic transformation of a telomerase immortalized fibroblast cell line.
Zongaro S; de Stanchina E; Colombo T; D'Incalci M; Giulotto E; Mondello C
Cancer Res; 2005 Dec; 65(24):11411-8. PubMed ID: 16357149
[TBL] [Abstract][Full Text] [Related]
51. Amplification of the Ect2 proto-oncogene and over-expression of Ect2 mRNA and protein in nickel compound and methylcholanthrene-transformed 10T1/2 mouse fibroblast cell lines.
Clemens F; Verma R; Ramnath J; Landolph JR
Toxicol Appl Pharmacol; 2005 Aug; 206(2):138-49. PubMed ID: 15967202
[TBL] [Abstract][Full Text] [Related]
52. Clonal analysis of the expression of multiple transformation phenotypes and tumorigenicity by morphologically transformed 10T1/2 cells.
Smith GJ; Bell WN; Grisham JW
Cancer Res; 1993 Feb; 53(3):500-8. PubMed ID: 8425183
[TBL] [Abstract][Full Text] [Related]
53. Apolipoprotein A-1 is a negative target of v-Jun overexpression.
Hadman M; Lin W; Bush L; Bos TJ
Oncogene; 1998 Feb; 16(5):655-60. PubMed ID: 9482111
[TBL] [Abstract][Full Text] [Related]
54. Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation.
Yang HS; Knies JL; Stark C; Colburn NH
Oncogene; 2003 Jun; 22(24):3712-20. PubMed ID: 12802278
[TBL] [Abstract][Full Text] [Related]
55. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts.
Tardif G; Hum D; Pelletier JP; Boileau C; Ranger P; Martel-Pelletier J
Arthritis Rheum; 2004 Aug; 50(8):2521-30. PubMed ID: 15334466
[TBL] [Abstract][Full Text] [Related]
56. Calmodulin and cyclin D anchoring sites on the Src-suppressed C kinase substrate, SSeCKS.
Lin X; Gelman IH
Biochem Biophys Res Commun; 2002 Feb; 290(5):1368-75. PubMed ID: 11820772
[TBL] [Abstract][Full Text] [Related]
57. Invasion of v-Fos(FBR)-transformed cells is dependent upon histone deacetylase activity and suppression of histone deacetylase regulated genes.
McGarry LC; Winnie JN; Ozanne BW
Oncogene; 2004 Jul; 23(31):5284-92. PubMed ID: 15107823
[TBL] [Abstract][Full Text] [Related]
58. Quantitative neoplastic transformation of C3H/10T1/2 fibroblasts: dependence upon the size of the initiated cell colony at confluence.
Mordan LJ; Martner JE; Bertram JS
Cancer Res; 1983 Sep; 43(9):4062-7. PubMed ID: 6871847
[TBL] [Abstract][Full Text] [Related]
59. Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype.
Kowara R; Karaczyn A; Cheng RY; Salnikow K; Kasprzak KS
Toxicol Appl Pharmacol; 2005 May; 205(1):1-10. PubMed ID: 15885260
[TBL] [Abstract][Full Text] [Related]
60. Bystander effect of normal fibroblasts for macrophages co-cultured with susceptible transformed target cells.
Kashchak N; Tsaryk R; Stoika R
Cell Biol Int; 2005 Jan; 29(1):41-50. PubMed ID: 15763498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
